Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Left Shifting of Language Related Activity Induced by Bihemispheric tDCS in Postacute Aphasia Following Stroke.

Feil S, Eisenhut P, Strakeljahn F, Müller S, Nauer C, Bansi J, Weber S, Liebs A, Lefaucheur JP, Kesselring J, Gonzenbach R, Mylius V.

Front Neurosci. 2019 Apr 26;13:295. doi: 10.3389/fnins.2019.00295. eCollection 2019.

2.

Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.

Joisten N, Rademacher A, Bloch W, Schenk A, Oberste M, Dalgas U, Langdon D, Caminada D, Purde MT, Gonzenbach R, Kool J, Zimmer P, Bansi J.

BMC Neurol. 2019 Mar 8;19(1):37. doi: 10.1186/s12883-019-1267-9.

3.

Reliability and validity of the inertial sensor-based Timed "Up and Go" test in individuals affected by stroke.

Wüest S, Massé F, Aminian K, Gonzenbach R, de Bruin ED.

J Rehabil Res Dev. 2016;53(5):599-610. doi: 10.1682/JRRD.2015.04.0065.

4.

Neurorehabilitation: applied neuroplasticity.

Khan F, Amatya B, Galea MP, Gonzenbach R, Kesselring J.

J Neurol. 2017 Mar;264(3):603-615. doi: 10.1007/s00415-016-8307-9. Epub 2016 Oct 24. Review.

PMID:
27778158
5.

Self-directed arm therapy at home after stroke with a sensor-based virtual reality training system.

Wittmann F, Held JP, Lambercy O, Starkey ML, Curt A, Höver R, Gassert R, Luft AR, Gonzenbach RR.

J Neuroeng Rehabil. 2016 Aug 11;13(1):75. doi: 10.1186/s12984-016-0182-1.

6.

A method to qualitatively assess arm use in stroke survivors in the home environment.

Leuenberger K, Gonzenbach R, Wachter S, Luft A, Gassert R.

Med Biol Eng Comput. 2017 Jan;55(1):141-150. doi: 10.1007/s11517-016-1496-7. Epub 2016 Apr 22.

7.

Improving activity recognition using a wearable barometric pressure sensor in mobility-impaired stroke patients.

Massé F, Gonzenbach RR, Arami A, Paraschiv-Ionescu A, Luft AR, Aminian K.

J Neuroeng Rehabil. 2015 Aug 25;12:72. doi: 10.1186/s12984-015-0060-2.

8.

Activity classification based on inertial and barometric pressure sensors at different anatomical locations.

Moncada-Torres A, Leuenberger K, Gonzenbach R, Luft A, Gassert R.

Physiol Meas. 2014 Jul;35(7):1245-63. doi: 10.1088/0967-3334/35/7/1245. Epub 2014 May 22.

9.

Chasing central nervous system plasticity: the brainstem's contribution to locomotor recovery in rats with spinal cord injury.

Zörner B, Bachmann LC, Filli L, Kapitza S, Gullo M, Bolliger M, Starkey ML, Röthlisberger M, Gonzenbach RR, Schwab ME.

Brain. 2014 Jun;137(Pt 6):1716-32. doi: 10.1093/brain/awu078. Epub 2014 Apr 15.

PMID:
24736305
10.

Infusion of anti-Nogo-A antibodies in adult rats increases growth and synapse related proteins in the absence of behavioral alterations.

Craveiro LM, Weinmann O, Roschitzki B, Gonzenbach RR, Zörner B, Montani L, Yee BK, Feldon J, Willi R, Schwab ME.

Exp Neurol. 2013 Dec;250:52-68. doi: 10.1016/j.expneurol.2013.09.015. Epub 2013 Sep 25.

PMID:
24076004
11.

Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients.

Zorina OI, Haueis P, Semmler A, Marti I, Gonzenbach RR, Guzek M, Kullak-Ublick GA, Weller M, Russmann S.

Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):872-80. doi: 10.1002/pds.3279. Epub 2012 Apr 20.

PMID:
22517594
12.

Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.

Gonzenbach RR, Zoerner B, Schnell L, Weinmann O, Mir AK, Schwab ME.

J Neurotrauma. 2012 Feb 10;29(3):567-78. doi: 10.1089/neu.2011.1752. Epub 2011 Oct 17.

13.

Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System).

Guzek M, Zorina OI, Semmler A, Gonzenbach RR, Huber M, Kullak-Ublick GA, Weller M, Russmann S.

Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):930-8. doi: 10.1002/pds.2197. Epub 2011 Jul 20.

PMID:
21774031
14.

Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents.

Zörner B, Filli L, Starkey ML, Gonzenbach R, Kasper H, Röthlisberger M, Bolliger M, Schwab ME.

Nat Methods. 2010 Sep;7(9):701-8.

PMID:
20836253
15.

Nogo-A antibodies and training reduce muscle spasms in spinal cord-injured rats.

Gonzenbach RR, Gasser P, Zörner B, Hochreutener E, Dietz V, Schwab ME.

Ann Neurol. 2010 Jul;68(1):48-57. doi: 10.1002/ana.22009.

PMID:
20582944
16.

Lamina-specific restoration of serotonergic projections after Nogo-A antibody treatment of spinal cord injury in rats.

Müllner A, Gonzenbach RR, Weinmann O, Schnell L, Liebscher T, Schwab ME.

Eur J Neurosci. 2008 Jan;27(2):326-33. doi: 10.1111/j.1460-9568.2007.06006.x.

PMID:
18215231
17.

Disinhibition of neurite growth to repair the injured adult CNS: focusing on Nogo.

Gonzenbach RR, Schwab ME.

Cell Mol Life Sci. 2008 Jan;65(1):161-76.

PMID:
17975707

Supplemental Content

Loading ...
Support Center